Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
11
PDM Quote, Financials, Valuation and Earnings
Last price:
$8.74
Seasonality move
:
-2.58%
Day range:
$8.43 - $8.84
52-week range:
$5.93 - $11.12
Dividend yield:
5.71%
P/E ratio:
--
P/S ratio:
1.90x
P/B ratio:
0.67x
Volume:
2.9M
Avg. volume:
949.3K
1-year change:
23.21%
Market cap:
$1.1B
Revenue:
$577.8M
EPS (TTM):
-$0.62
Analysts' Opinion
-
Consensus RatingPiedmont Office Realty Trust has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Piedmont Office Realty Trust has an estimated upside of 25.57% from its current price of $8.76.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $8.76.
Fair Value
-
According to the consensus of 0 analysts, Piedmont Office Realty Trust has 25.57% upside to fair value with a price target of -- per share.
PDM vs. S&P 500
-
Over the past 5 trading days, Piedmont Office Realty Trust has underperformed the S&P 500 by -4.51% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Piedmont Office Realty Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Piedmont Office Realty Trust revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Piedmont Office Realty Trust reported revenues of $139.3M.
Earnings Growth
-
Piedmont Office Realty Trust earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Piedmont Office Realty Trust reported earnings per share of -$0.09.
Enterprise value:
3.2B
EV / Invested capital:
0.82x
Price / LTM sales:
1.90x
EV / EBIT:
74.43x
EV / Revenue:
5.55x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1,502.39x
Price / Operating cash flow:
52.40x
Enterprise value / EBITDA:
11.55x
Gross Profit (TTM):
$337.8M
Return On Assets:
-1.89%
Net Income Margin (TTM):
-13.47%
Return On Equity:
-4.56%
Return On Invested Capital:
-2.02%
Operating Margin:
13.57%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $554.7M | $579.6M | $572.4M | $147M | $139.3M | |
| Gross Profit | $332.3M | $343.9M | $337.8M | $87.1M | $81.8M | |
| Operating Income | $83.5M | $81.3M | $75.6M | $21.8M | $18.9M | |
| EBITDA | $318.2M | $381.4M | $274.9M | $68.7M | $76.6M | |
| Diluted EPS | $0.32 | $0.44 | -$0.62 | -$0.14 | -$0.09 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $191.7M | $309.6M | $193.8M | $201.7M | $333.8M | |
| Total Assets | $3.8B | $3.8B | $4.2B | $4.1B | $4.1B | |
| Current Liabilities | $157.4M | $201.3M | $182.1M | $210.6M | $249.9M | |
| Total Liabilities | $1.8B | $1.9B | $2.4B | $2.3B | $2.5B | |
| Total Equity | $1.9B | $1.9B | $1.8B | $1.8B | $1.6B | |
| Total Debt | $1.6B | $1.7B | $2.1B | $2.1B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $241.2M | $211.8M | $182.7M | $65.3M | $42.9M | |
| Cash From Investing | -$395.5M | -$17.9M | -$159.6M | -$48.4M | -$33M | |
| Cash From Financing | $152.9M | -$195.7M | $102.9M | -$16.1M | -$16.7M | |
| Free Cash Flow | $106.5M | $72.5M | -$2.1M | $23.6M | -$111K | |
PDM
Sector
Market Cap
$1.1B
$1.1B
Price % of 52-Week High
78.81%
82.88%
Dividend Yield
5.71%
3.41%
Shareholder Yield
--
3.4%
1-Year Price Total Return
23.21%
-3.52%
Beta (5-Year)
1.195
0.877
Dividend yield:
5.71%
Annualized payout:
$0.67
Payout ratio:
-80.37%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$9.09
200-day SMA
Buy
Level
$8.35
Bollinger Bands (100)
Sell
Level
9.01 - 10.19
Chaikin Money Flow
Buy
Level
122.6M
20-day SMA
Sell
Level
$9.27
Relative Strength Index (RSI14)
Sell
Level
36.41
ADX Line
Sell
Level
13.78
Williams %R
Neutral
Level
-70.5357
50-day SMA
Sell
Level
$9.78
MACD (12, 26)
Sell
Level
-0.23
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Sell
Level
-6.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.2862)
Sell
CA Score
(Annual)
Level (-0.6347)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.5507)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Piedmont Office Realty Trust Inc is a real estate investment trust engaged in the acquisition, development, and management of commercial real estate properties throughout the U.S. The company's real estate portfolio is mainly composed of office properties located in the majority of American metropolitan areas. Piedmont derives majority of its revenue in the form of rental income from tenants in mid- to long-term lease agreements. The vast majority of the company's revenue comes from the leasing of its assets in Washington D.C., New York City, Chicago, Atlanta, Minneapolis, Dallas, and Boston. Piedmont's large customers in terms of rental revenue are U.S. Government entities, business services companies, and financial institutions.
Stock Forecast FAQ
In the current month, PDM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PDM average analyst price target in the past 3 months is --.
-
Where Will Piedmont Office Realty Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Piedmont Office Realty Trust share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Piedmont Office Realty Trust?
Analysts are divided on their view about Piedmont Office Realty Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Piedmont Office Realty Trust is a Sell and believe this share price will drop from its current level to --.
-
What Is Piedmont Office Realty Trust's Price Target?
The price target for Piedmont Office Realty Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PDM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Piedmont Office Realty Trust is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PDM?
You can purchase shares of Piedmont Office Realty Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Piedmont Office Realty Trust shares.
-
What Is The Piedmont Office Realty Trust Share Price Today?
Piedmont Office Realty Trust was last trading at $8.74 per share. This represents the most recent stock quote for Piedmont Office Realty Trust. Yesterday, Piedmont Office Realty Trust closed at $8.76 per share.
-
How To Buy Piedmont Office Realty Trust Stock Online?
In order to purchase Piedmont Office Realty Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
